Skip to content

Use of Vibration During Constraint-induced Movement Therapy

Use of Vibration During Constraint-induced Movement Therapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06452576
Acronym
CPT
Enrollment
8
Registered
2024-06-11
Start date
2024-07-15
Completion date
2024-09-09
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiparesis

Keywords

constraint-induced movement therapy

Brief summary

The purpose of this study is to determine whether the hand function will improve more by using low-level vibration during constraint-induced movement therapy (CIMT), compared to CIMT alone without vibration.

Detailed description

The low-level vibration has been shown to increase therapy outcome when used as an adjunct to therapy in adults with hemiparesis. Children who participates in the CIMT camp at MUSC will be recruited to take part in the study. Participating children will wear a watch device on their weaker arm during CIMT. The watch will vibrate only for the children who were assigned to the treatment group.

Interventions

DEVICEVibration

Watch vibrates.

A splint or mitt is placed on the stronger, unaffected hand to encourage use of the affected upper limb in therapy.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 9 Years
Healthy volunteers
No

Inclusion criteria

* Unilateral upper limb motor weakness * Can use the affected upper limb as a gross assist during play and self-care activities * Ambulatory for their age with intact balance and protective reactions in the less involved upper limb.

Exclusion criteria

* Developmental delays limiting spontaneous use of the affected upper limb * Other health impairment

Design outcomes

Primary

MeasureTime frameDescription
Box and Block Testpre-therapy and post-therapy, up to 5 consecutive daysnumber of blocks moved in a minute

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026